A Phase 1 Randomized, Placebo-Controlled, Blinded Study Evaluating the Safety, Tolerability, and Pharmacokinetics of ARC-001 in Participants Undergoing Third Molar Extraction

Summary

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?

Eligibility

Age range

18–55 years

Sex

All

Healthy volunteers

No

Interventions

• Drug
  ARC-001

  Gel formulation containing investigational anesthetic.

• Drug
  Placebo gel

  Gel that contains no active ingredients.

Location